Best Practice & Research Clinical Haematology
Volume 21, Issue 2 , Pages 149-164, June 2008

Polymorphisms of cytokine and innate immunity genes and GVHD

  • A.M. Dickinson (Professor of Marrow Transplant Biology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 191 282 4259; Fax: +44 191 222 6794.

School of Clinical and Laboratory Sciences, Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK

Department of Haematology/Oncology, University Medical Centre of Regensburg, Germany

In the last 10 years, non-HLA genotypes have been investigated for their potential roles in the occurrence and severity of graft-versus-host disease (GVHD) as well as for their contribution to overall transplant-related mortality, infectious episodes, and overall survival. This chapter will review the latest results of cytokine gene polymorphisms between patient and donor which may cause the production of high or low levels of cytokines during the three-stage process of the GVHD ‘cytokine storm’. More recent investigations into innate immunity and the interaction with subsequent downstream cytokine production and ultimate tissue damage are discussed. The potential of these non-HLA genetics to aid in predicting GVHD and post-transplant survival and the relevance of this information to the clinic are reviewed.

Key words: haematopoietic stem-cell transplantation, non-HLA genetics, graft-versus-host disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-6926(08)00035-2

doi:10.1016/j.beha.2008.03.004

Best Practice & Research Clinical Haematology
Volume 21, Issue 2 , Pages 149-164, June 2008